Financial results - SEMPRE GYN MEDICAL SRL

Financial Summary - Sempre Gyn Medical Srl
Unique identification code: 32420371
Registration number: J40/13510/2013
Nace: 8622
Sales - Ron
24.811
Net Profit - Ron
10.446
Employee
1
The most important financial indicators for the company Sempre Gyn Medical Srl - Unique Identification Number 32420371: sales in 2023 was 24.811 euro, registering a net profit of 10.446 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Sempre Gyn Medical Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 45.455 38.265 59.383 44.240 31.249 853 49.325 37.388 32.105 24.811
Total Income - EUR 46.008 38.297 59.389 44.240 31.444 960 49.373 37.424 32.120 24.811
Total Expenses - EUR 18.519 11.193 12.895 6.392 5.074 1.060 9.500 6.414 7.453 14.122
Gross Profit/Loss - EUR 27.488 27.105 46.494 37.848 26.370 -100 39.872 31.010 24.667 10.689
Net Profit/Loss - EUR 26.108 25.956 44.712 36.520 25.426 -129 38.480 29.910 23.889 10.446
Employees 0 0 0 0 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -22.5%, from 32.105 euro in the year 2022, to 24.811 euro in 2023. The Net Profit decreased by -13.370 euro, from 23.889 euro in 2022, to 10.446 in the last year.

Check the financial reports for the company - Sempre Gyn Medical Srl

Rating financiar

Financial Rating -
Sempre Gyn Medical Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Sempre Gyn Medical Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Sempre Gyn Medical Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Sempre Gyn Medical Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Sempre Gyn Medical Srl - CUI 32420371

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 0 0 3.571 4.121 5.019 3.514 2.486
Current Assets 30.070 53.129 45.144 49.080 25.684 8.213 34.731 25.373 23.160 11.989
Inventories 0 0 0 0 0 497 0 0 0 0
Receivables 0 18.957 8.424 25.008 13.109 3.096 22.843 16.064 21.316 11.107
Cash 30.070 34.172 36.720 24.072 12.575 4.620 11.889 9.309 1.844 882
Shareholders Funds 26.376 52.552 44.980 48.428 25.684 124 38.601 30.152 24.132 10.689
Social Capital 223 225 223 219 215 211 207 202 203 202
Debts 3.694 578 164 652 0 11.660 251 240 2.542 3.786
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 11.989 euro in 2023 which includes Inventories of 0 euro, Receivables of 11.107 euro and cash availability of 882 euro.
The company's Equity was valued at 10.689 euro, while total Liabilities amounted to 3.786 euro. Equity decreased by -13.370 euro, from 24.132 euro in 2022, to 10.689 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Sempre Gyn Medical Srl

Comments - Sempre Gyn Medical Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.